The Patent Finder

Terms ending in 2033

AbbVie Inc.

Every in-force patent on AbbVie Inc.'s record whose computed term ends in 2033, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 9,006,247Apoptosis-Inducing Agents for the Treatment of Cancer and Immune and Autoimmune Diseases
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
US D807,923Interface Portion of a Pump
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
US 9,102,722Composition and Method for the Diagnosis and Treatment of Diseases Associated with Neurite Degeneration
Müller, Bernhard Klaus, DR.
In force
 · Low confidence
Müller, Bernhard Klaus, DR.In forceLow confidence
US 9,365,643Antibodies That Bind to Repulsive Guidance Molecule a (RGMA)
Müller, Bernhard Klaus, DR.
In force
 · Medium confidence
Müller, Bernhard Klaus, DR.In forceMedium confidence
US 10,106,602Isolated Monoclonal Anti-Repulsive Guidance Molecule a Antibodies and Uses Thereof
Müller, Bernhard Klaus, DR.
In force
 · Medium confidence
Müller, Bernhard Klaus, DR.In forceMedium confidence
US D810,278Injector Device
In force
 · High confidence
AbbVie Biotechnology Ltd. (Puerto Rico Branch)In forceHigh confidence
US D810,279Injector Device
In force
 · High confidence
AbbVie Biotechnology Ltd. (Puerto Rico Branch)In forceHigh confidence
US 9,447,051Diaminopyrimidines And Uses Thereof
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
US 8,986,972Nucleic Acid Encoding DLL3 Antibodies
In force
 · Medium confidence
AbbVie Stemcentrx LLCIn forceMedium confidence
US 8,969,325TRPV1 Antagonists
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
72 more term ends in 2033 · Pro
10 of 82 patents shown. Soonest term end first, then patent number.
Pro members see all 82.
Upgrade to Pro
78 of these are in force and held by AbbVie Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited